Printer Friendly Email a Friend PDF

Acupuncture Today – November, 2005, Vol. 06, Issue 11

Acupuncture Poll

By Editorial Staff

The Acupuncture Poll question for August 2005 was:

In your opinion, is the randomized, controlled trial an appropriate format for measuring the effectiveness of acupuncture?

Results:

image - Copyright – Stock Photo / Register Mark

These results are based upon 79 responses.

As this is a voluntary, non-scientific survey, caution should be used in generalizing the results. The following is a sample of the comments received in response to the poll, along with how that person voted:

No: With "sham acupuncture" often nearly as effective as "real acupuncture," we clearly need to use a method that is larger than the scientific method of separation of variables. Our medicine is inclusive, and not separable.

Yes: While a randomized, controlled trial may not be the only format, it is certainly the gold standard for medical research. If our methods work, then the results will be borne out by the studies. If not, then we have to eliminate ineffective treatment protocols and develop better ones.

No: This form of study requires a simple, singular object and is not accurate for multivariate testing. The real world is full of variables, so conclusions reached would be very limited. Pharmaceuticals do well in single-controlled studies, but watch out when they hit the market and cause a lot of pain, suffering, and more grief. There would be less side-effects if the testing model was more realistic.

No: "Sham" acupuncture could still have an effect on the body. It's not the same as a placebo.

Yes: I think the randomized treatment is important for acupuncture research. It is a basic rule in scientific research.


To vote in the current Acupuncture Poll, or to review comments and responses to previous poll questions, visit www.acupuncturetoday.com/acupuncturepoll.


Acupuncture Today editorial staff members research, investigate and write articles for the publication on an ongoing basis. To contact the Editorial Department or submit an article of your own for consideration, email mailto: .


To report inappropriate ads, click here.